Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells.
Yunokawa M; Koizumi F; Kitamura Y; Katanasaka Y; Okamoto N; Kodaira M; Yonemori K; Shimizu C; Ando M; Masutomi K; Yoshida T; Fujiwara Y; Tamura K; Cancer Science, 2012, vol. 103, issue 9, p 1665, ISSN 13497006. ISBN 13497006.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef